

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to arsenic-containing substance (GO:0071243) | 9.36860450 |
| 2 | L-ascorbic acid metabolic process (GO:0019852) | 8.64898514 |
| 3 | negative regulation of leukocyte chemotaxis (GO:0002689) | 7.91598017 |
| 4 | oxygen transport (GO:0015671) | 7.75198256 |
| 5 | sequestering of extracellular ligand from receptor (GO:0035581) | 7.36884909 |
| 6 | regulation of histone phosphorylation (GO:0033127) | 7.09525613 |
| 7 | stress fiber assembly (GO:0043149) | 6.85881193 |
| 8 | photoreceptor cell differentiation (GO:0046530) | 6.69664384 |
| 9 | eye photoreceptor cell differentiation (GO:0001754) | 6.69664384 |
| 10 | receptor recycling (GO:0001881) | 6.46313873 |
| 11 | bone trabecula formation (GO:0060346) | 5.88013459 |
| 12 | regulation of meiosis I (GO:0060631) | 5.77393991 |
| 13 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.61630463 |
| 14 | extracellular fibril organization (GO:0043206) | 5.60281083 |
| 15 | vesicle targeting (GO:0006903) | 5.59107901 |
| 16 | protein heterotrimerization (GO:0070208) | 5.54987768 |
| 17 | ncRNA 3-end processing (GO:0043628) | 5.39222626 |
| 18 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 5.26894633 |
| 19 | negative regulation of heart growth (GO:0061117) | 5.26894633 |
| 20 | positive regulation of meiosis (GO:0045836) | 5.17429707 |
| 21 | vitamin A metabolic process (GO:0006776) | 5.03996025 |
| 22 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 4.91439005 |
| 23 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 4.91439005 |
| 24 | fibril organization (GO:0097435) | 4.88161795 |
| 25 | type B pancreatic cell proliferation (GO:0044342) | 4.80508122 |
| 26 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.77214240 |
| 27 | positive regulation of meiotic cell cycle (GO:0051446) | 4.73951175 |
| 28 | protein retention in ER lumen (GO:0006621) | 4.62625609 |
| 29 | adhesion of symbiont to host cell (GO:0044650) | 4.59410929 |
| 30 | virion attachment to host cell (GO:0019062) | 4.59410929 |
| 31 | lung vasculature development (GO:0060426) | 4.56000313 |
| 32 | pericardium development (GO:0060039) | 4.54574234 |
| 33 | regulation of monocyte chemotaxis (GO:0090025) | 4.47469501 |
| 34 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.43277902 |
| 35 | cellular zinc ion homeostasis (GO:0006882) | 4.41503758 |
| 36 | gas transport (GO:0015669) | 4.35617042 |
| 37 | endocardial cushion development (GO:0003197) | 4.25488235 |
| 38 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 4.25095216 |
| 39 | response to arsenic-containing substance (GO:0046685) | 4.14895889 |
| 40 | substrate-dependent cell migration (GO:0006929) | 4.12016337 |
| 41 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.11904223 |
| 42 | dermatan sulfate biosynthetic process (GO:0030208) | 4.02883070 |
| 43 | cell aggregation (GO:0098743) | 4.00196572 |
| 44 | cartilage condensation (GO:0001502) | 4.00196572 |
| 45 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.94552678 |
| 46 | inner cell mass cell proliferation (GO:0001833) | 3.89298596 |
| 47 | metanephric mesenchyme development (GO:0072075) | 3.88645160 |
| 48 | positive regulation of mitochondrial fission (GO:0090141) | 3.87017155 |
| 49 | endodermal cell differentiation (GO:0035987) | 3.84147331 |
| 50 | negative regulation of viral release from host cell (GO:1902187) | 3.83247553 |
| 51 | extracellular regulation of signal transduction (GO:1900115) | 3.81561573 |
| 52 | extracellular negative regulation of signal transduction (GO:1900116) | 3.81561573 |
| 53 | negative regulation of axon guidance (GO:1902668) | 3.79121650 |
| 54 | blood vessel maturation (GO:0001955) | 3.75582221 |
| 55 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.74957976 |
| 56 | positive regulation of p38MAPK cascade (GO:1900745) | 3.74718073 |
| 57 | response to hyperoxia (GO:0055093) | 3.71346025 |
| 58 | response to increased oxygen levels (GO:0036296) | 3.71346025 |
| 59 | adhesion of symbiont to host (GO:0044406) | 3.71236357 |
| 60 | collagen fibril organization (GO:0030199) | 3.70341370 |
| 61 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.69802522 |
| 62 | dermatan sulfate metabolic process (GO:0030205) | 3.69531597 |
| 63 | outer ear morphogenesis (GO:0042473) | 3.68675185 |
| 64 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.68281535 |
| 65 | histone H2A ubiquitination (GO:0033522) | 3.62278372 |
| 66 | female mating behavior (GO:0060180) | 3.59718178 |
| 67 | smooth muscle tissue development (GO:0048745) | 3.59267006 |
| 68 | regulation of female receptivity (GO:0045924) | 3.54716291 |
| 69 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.53807865 |
| 70 | cell migration involved in heart development (GO:0060973) | 3.52008859 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.49049791 |
| 72 | skin morphogenesis (GO:0043589) | 3.48640699 |
| 73 | middle ear morphogenesis (GO:0042474) | 3.48158503 |
| 74 | positive regulation of male gonad development (GO:2000020) | 3.46311793 |
| 75 | cellular response to vitamin (GO:0071295) | 3.43389697 |
| 76 | collagen catabolic process (GO:0030574) | 3.43058789 |
| 77 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 3.42497525 |
| 78 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.41436727 |
| 79 | mesenchymal cell proliferation (GO:0010463) | 3.38048654 |
| 80 | kidney mesenchyme development (GO:0072074) | 3.37970034 |
| 81 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.36241678 |
| 82 | zinc ion homeostasis (GO:0055069) | 3.35796481 |
| 83 | collagen metabolic process (GO:0032963) | 3.34621773 |
| 84 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.32870177 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.32285201 |
| 86 | inner ear receptor cell development (GO:0060119) | 3.29186700 |
| 87 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.28450698 |
| 88 | respiratory tube development (GO:0030323) | 3.28158899 |
| 89 | bone resorption (GO:0045453) | 3.26878572 |
| 90 | chondrocyte development (GO:0002063) | 3.23362267 |
| 91 | extracellular matrix disassembly (GO:0022617) | 3.22869699 |
| 92 | snRNA processing (GO:0016180) | 3.22051325 |
| 93 | ovulation cycle (GO:0042698) | 3.19553907 |
| 94 | glutathione derivative biosynthetic process (GO:1901687) | 3.17994494 |
| 95 | glutathione derivative metabolic process (GO:1901685) | 3.17994494 |
| 96 | chondrocyte proliferation (GO:0035988) | 3.16873066 |
| 97 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.16179726 |
| 98 | blood circulation (GO:0008015) | 3.15903968 |
| 99 | response to laminar fluid shear stress (GO:0034616) | 3.14770308 |
| 100 | response to redox state (GO:0051775) | 3.13510181 |
| 101 | nonmotile primary cilium assembly (GO:0035058) | 3.13338052 |
| 102 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.13232040 |
| 103 | multicellular organismal catabolic process (GO:0044243) | 3.12702288 |
| 104 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.11594242 |
| 105 | olfactory bulb development (GO:0021772) | 3.10280401 |
| 106 | negative regulation of viral entry into host cell (GO:0046597) | 3.10077657 |
| 107 | positive regulation of astrocyte differentiation (GO:0048711) | 3.09749233 |
| 108 | homocysteine metabolic process (GO:0050667) | 3.08622318 |
| 109 | pattern specification involved in kidney development (GO:0061004) | 3.08218548 |
| 110 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.08189709 |
| 111 | positive regulation of DNA recombination (GO:0045911) | 3.08150274 |
| 112 | lung lobe morphogenesis (GO:0060463) | 3.07262143 |
| 113 | gonadal mesoderm development (GO:0007506) | 3.06090941 |
| 114 | renal tubule development (GO:0061326) | 3.05697603 |
| 115 | nucleoside diphosphate catabolic process (GO:0009134) | 3.05427688 |
| 116 | lymphangiogenesis (GO:0001946) | 3.04131479 |
| 117 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.02552723 |
| 118 | mesodermal cell differentiation (GO:0048333) | 3.01884821 |
| 119 | positive regulation of odontogenesis (GO:0042482) | 3.01623878 |
| 120 | cellular response to fluid shear stress (GO:0071498) | 3.01481153 |
| 121 | multicellular organismal metabolic process (GO:0044236) | 3.01010784 |
| 122 | negative regulation of leukocyte migration (GO:0002686) | 3.00965102 |
| 123 | cellular response to nicotine (GO:0071316) | 3.00930370 |
| 124 | cell adhesion mediated by integrin (GO:0033627) | 3.00858829 |
| 125 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.99911017 |
| 126 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.99767954 |
| 127 | tooth mineralization (GO:0034505) | 2.98582551 |
| 128 | polarized epithelial cell differentiation (GO:0030859) | 2.96729867 |
| 129 | negative regulation of osteoblast proliferation (GO:0033689) | 2.95339553 |
| 130 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.93949482 |
| 131 | axon extension involved in axon guidance (GO:0048846) | 2.93527742 |
| 132 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.93527742 |
| 133 | regulation of p38MAPK cascade (GO:1900744) | 2.92670359 |
| 134 | regulation of axon guidance (GO:1902667) | 2.92538728 |
| 135 | blood vessel remodeling (GO:0001974) | 2.91153301 |
| 136 | cellular response to vitamin D (GO:0071305) | 2.90936726 |
| 137 | regulation of female gonad development (GO:2000194) | 2.90440484 |
| 138 | extracellular matrix assembly (GO:0085029) | 2.90414527 |
| 139 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.90252955 |
| 140 | face morphogenesis (GO:0060325) | 2.87871558 |
| 141 | regulation of male gonad development (GO:2000018) | 2.85372585 |
| 142 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.83156180 |
| 143 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.82471758 |
| 144 | positive regulation of osteoblast proliferation (GO:0033690) | 2.82275366 |
| 145 | regulation of plasminogen activation (GO:0010755) | 2.81541756 |
| 146 | induction of positive chemotaxis (GO:0050930) | 2.80425424 |
| 147 | positive regulation of protein autophosphorylation (GO:0031954) | 2.80011695 |
| 148 | keratan sulfate catabolic process (GO:0042340) | 2.78701060 |
| 149 | proteoglycan biosynthetic process (GO:0030166) | 2.74619750 |
| 150 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74263431 |
| 151 | regulation of smooth muscle cell migration (GO:0014910) | 2.71972883 |
| 152 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.70939730 |
| 153 | regulation of metalloenzyme activity (GO:0048552) | 2.66205351 |
| 154 | cellular response to interferon-alpha (GO:0035457) | 2.64199412 |
| 155 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.64066060 |
| 156 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.64066060 |
| 157 | cell differentiation involved in metanephros development (GO:0072202) | 2.63177908 |
| 158 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.62870455 |
| 159 | peptidyl-proline hydroxylation (GO:0019511) | 2.62840696 |
| 160 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.62027346 |
| 161 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.59948702 |
| 162 | positive regulation of fibroblast migration (GO:0010763) | 2.58350395 |
| 163 | regulation of interleukin-8 secretion (GO:2000482) | 2.58171892 |
| 164 | platelet dense granule organization (GO:0060155) | 2.56513533 |
| 165 | proteoglycan metabolic process (GO:0006029) | 2.55101712 |
| 166 | cellular response to amino acid stimulus (GO:0071230) | 2.53453005 |
| 167 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.51512371 |
| 168 | extracellular matrix organization (GO:0030198) | 2.50396509 |
| 169 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.50232451 |
| 170 | extracellular structure organization (GO:0043062) | 2.49527980 |
| 171 | positive regulation of positive chemotaxis (GO:0050927) | 2.49256906 |
| 172 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.48699192 |
| 173 | positive regulation of extracellular matrix organization (GO:1903055) | 2.48172497 |
| 174 | negative chemotaxis (GO:0050919) | 2.46501598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.52818746 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.11517882 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.86983041 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.60706730 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.96648697 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.73977634 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61890986 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.35381708 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.35381708 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.35381708 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12243270 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11461743 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10967757 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08875929 |
| 15 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.06362755 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.03192530 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.96723921 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.92324036 |
| 19 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.90543226 |
| 20 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86927471 |
| 21 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.82747920 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81527325 |
| 23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.80848015 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80487745 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.78225146 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78009009 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.75424506 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74266792 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73422463 |
| 30 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.73029465 |
| 31 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.72877106 |
| 32 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72427692 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.72288079 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70395179 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69658413 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68600220 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68600220 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.62931719 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.61932421 |
| 40 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.61854174 |
| 41 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.59239124 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53179834 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.48158306 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47511067 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.47163475 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.46362910 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45395947 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44753179 |
| 49 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.44531175 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43802875 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40068044 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39497528 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39395065 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39078565 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37219315 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37085493 |
| 57 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35723055 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35640070 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35629438 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.35061399 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.34562976 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31332342 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29832506 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29356534 |
| 65 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.29245022 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28440429 |
| 67 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.25438758 |
| 68 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.25410024 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24138036 |
| 70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23402846 |
| 71 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.22613591 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21838442 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20484094 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20303196 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19547753 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19276861 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.19014005 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18606299 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16109655 |
| 80 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15833288 |
| 81 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15776488 |
| 82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14951078 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14267085 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14195685 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13862334 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13862334 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13320093 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13194316 |
| 89 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12480161 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12153123 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11555259 |
| 92 | * PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 1.11390099 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10564768 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10327160 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09886426 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09754851 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09644249 |
| 98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09587860 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09444772 |
| 100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09343823 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09306830 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09255112 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08471824 |
| 104 | JUN_21703547_ChIP-Seq_K562_Human | 1.07666601 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06372513 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05002333 |
| 107 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04470220 |
| 108 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.04150447 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04127617 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03841574 |
| 111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03447879 |
| 112 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.03406274 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02420849 |
| 114 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01467284 |
| 115 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00649874 |
| 116 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00183901 |
| 117 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98984369 |
| 118 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98858301 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98840378 |
| 120 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97689933 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97258850 |
| 122 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97064902 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97010825 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96291216 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95438033 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95419742 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95412488 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94094841 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93794401 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93529105 |
| 131 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93306207 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93306207 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92424412 |
| 134 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92407387 |
| 135 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92045960 |
| 136 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90216624 |
| 137 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88634030 |
| 138 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88604499 |
| 139 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88304230 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88236531 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85558346 |
| 142 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84834380 |
| 143 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84754267 |
| 144 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82771502 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82491715 |
| 146 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82491715 |
| 147 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.82479894 |
| 148 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82164611 |
| 149 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81604925 |
| 150 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79300590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001958_emphysema | 6.49796677 |
| 2 | MP0006054_spinal_hemorrhage | 6.09409082 |
| 3 | MP0010368_abnormal_lymphatic_system | 4.58350943 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.44751740 |
| 5 | MP0001542_abnormal_bone_strength | 4.17686020 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.98417948 |
| 7 | MP0003011_delayed_dark_adaptation | 3.74693296 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.53451193 |
| 9 | MP0003279_aneurysm | 3.29902529 |
| 10 | MP0004883_abnormal_blood_vessel | 3.08699576 |
| 11 | MP0009384_cardiac_valve_regurgitation | 2.80383714 |
| 12 | MP0005275_abnormal_skin_tensile | 2.64035760 |
| 13 | MP0000049_abnormal_middle_ear | 2.56555806 |
| 14 | MP0002254_reproductive_system_inflammat | 2.41324250 |
| 15 | MP0005623_abnormal_meninges_morphology | 2.40490865 |
| 16 | MP0005508_abnormal_skeleton_morphology | 2.35752051 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.27273367 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.26060581 |
| 19 | MP0001177_atelectasis | 2.25064733 |
| 20 | MP0005164_abnormal_response_to | 2.06682553 |
| 21 | MP0005257_abnormal_intraocular_pressure | 2.02319460 |
| 22 | MP0002249_abnormal_larynx_morphology | 1.91454403 |
| 23 | MP0009250_abnormal_appendicular_skeleto | 1.89954664 |
| 24 | MP0004484_altered_response_of | 1.89653809 |
| 25 | MP0003283_abnormal_digestive_organ | 1.89077634 |
| 26 | MP0000604_amyloidosis | 1.88802698 |
| 27 | MP0010030_abnormal_orbit_morphology | 1.87527489 |
| 28 | MP0000534_abnormal_ureter_morphology | 1.83289970 |
| 29 | MP0003115_abnormal_respiratory_system | 1.82528281 |
| 30 | MP0000163_abnormal_cartilage_morphology | 1.82168500 |
| 31 | MP0000767_abnormal_smooth_muscle | 1.81830712 |
| 32 | MP0001849_ear_inflammation | 1.77709611 |
| 33 | MP0001348_abnormal_lacrimal_gland | 1.75655752 |
| 34 | MP0005390_skeleton_phenotype | 1.71534197 |
| 35 | MP0004134_abnormal_chest_morphology | 1.64148576 |
| 36 | MP0005595_abnormal_vascular_smooth | 1.59426855 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.55463598 |
| 38 | MP0002896_abnormal_bone_mineralization | 1.52395996 |
| 39 | MP0000681_abnormal_thyroid_gland | 1.50779584 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.50082054 |
| 41 | MP0003878_abnormal_ear_physiology | 1.50082054 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.46794676 |
| 43 | MP0002115_abnormal_skeleton_extremities | 1.43653811 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.41421680 |
| 45 | MP0003941_abnormal_skin_development | 1.39303596 |
| 46 | MP0001879_abnormal_lymphatic_vessel | 1.39075305 |
| 47 | MP0002133_abnormal_respiratory_system | 1.38647429 |
| 48 | MP0005388_respiratory_system_phenotype | 1.38647429 |
| 49 | MP0002295_abnormal_pulmonary_circulatio | 1.38365056 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.37455444 |
| 51 | MP0000762_abnormal_tongue_morphology | 1.37305575 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.33252840 |
| 53 | MP0003795_abnormal_bone_structure | 1.33012435 |
| 54 | MP0003938_abnormal_ear_development | 1.32033966 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.31988194 |
| 56 | MP0000428_abnormal_craniofacial_morphol | 1.31916260 |
| 57 | MP0005451_abnormal_body_composition | 1.28434414 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.25840049 |
| 59 | MP0004885_abnormal_endolymph | 1.24585004 |
| 60 | MP0002102_abnormal_ear_morphology | 1.21222644 |
| 61 | MP0001299_abnormal_eye_distance/ | 1.20962800 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.17896034 |
| 63 | MP0001270_distended_abdomen | 1.17508167 |
| 64 | MP0002933_joint_inflammation | 1.15786027 |
| 65 | MP0002113_abnormal_skeleton_development | 1.15315359 |
| 66 | MP0001175_abnormal_lung_morphology | 1.14814039 |
| 67 | MP0005171_absent_coat_pigmentation | 1.08420016 |
| 68 | MP0005197_abnormal_uvea_morphology | 1.07487091 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 1.02357785 |
| 70 | MP0003186_abnormal_redox_activity | 1.01124653 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.00149414 |
| 72 | MP0003091_abnormal_cell_migration | 1.00043798 |
| 73 | MP0009053_abnormal_anal_canal | 0.98961318 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.98454279 |
| 75 | MP0002108_abnormal_muscle_morphology | 0.97032636 |
| 76 | MP0006082_CNS_inflammation | 0.96330222 |
| 77 | MP0009840_abnormal_foam_cell | 0.93760940 |
| 78 | MP0002116_abnormal_craniofacial_bone | 0.93411343 |
| 79 | MP0000427_abnormal_hair_cycle | 0.92892704 |
| 80 | MP0004272_abnormal_basement_membrane | 0.92781848 |
| 81 | MP0002177_abnormal_outer_ear | 0.91217547 |
| 82 | MP0000613_abnormal_salivary_gland | 0.89180561 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.88182036 |
| 84 | MP0000733_abnormal_muscle_development | 0.86581011 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.85604167 |
| 86 | MP0003123_paternal_imprinting | 0.84555457 |
| 87 | MP0003755_abnormal_palate_morphology | 0.84178902 |
| 88 | MP0002114_abnormal_axial_skeleton | 0.80976685 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.80842850 |
| 90 | MP0002736_abnormal_nociception_after | 0.80766961 |
| 91 | MP0002128_abnormal_blood_circulation | 0.79699221 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78341083 |
| 93 | MP0002009_preneoplasia | 0.78136925 |
| 94 | MP0004858_abnormal_nervous_system | 0.78031317 |
| 95 | MP0001243_abnormal_dermal_layer | 0.77421659 |
| 96 | MP0000432_abnormal_head_morphology | 0.75615662 |
| 97 | MP0005165_increased_susceptibility_to | 0.75037664 |
| 98 | MP0002168_other_aberrant_phenotype | 0.74964157 |
| 99 | MP0002163_abnormal_gland_morphology | 0.74467513 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.74297860 |
| 101 | MP0008775_abnormal_heart_ventricle | 0.73445937 |
| 102 | MP0001968_abnormal_touch/_nociception | 0.72209319 |
| 103 | MP0005023_abnormal_wound_healing | 0.72021795 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.71588820 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.71588820 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.70723529 |
| 107 | MP0003942_abnormal_urinary_system | 0.70282237 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.70052839 |
| 109 | MP0003828_pulmonary_edema | 0.69728409 |
| 110 | MP0004133_heterotaxia | 0.67894563 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.67256917 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.67075540 |
| 113 | * MP0004085_abnormal_heartbeat | 0.65590616 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.64182120 |
| 115 | MP0002109_abnormal_limb_morphology | 0.63772927 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.63094442 |
| 117 | MP0000751_myopathy | 0.62292222 |
| 118 | MP0002111_abnormal_tail_morphology | 0.62213093 |
| 119 | MP0002932_abnormal_joint_morphology | 0.61353359 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.60412090 |
| 121 | MP0003935_abnormal_craniofacial_develop | 0.58972778 |
| 122 | MP0001915_intracranial_hemorrhage | 0.58655152 |
| 123 | * MP0001970_abnormal_pain_threshold | 0.57465417 |
| 124 | MP0003448_altered_tumor_morphology | 0.56716471 |
| 125 | MP0003385_abnormal_body_wall | 0.55988738 |
| 126 | MP0002233_abnormal_nose_morphology | 0.55852857 |
| 127 | MP0000749_muscle_degeneration | 0.55672346 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.55225043 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.55173319 |
| 130 | MP0001614_abnormal_blood_vessel | 0.54671268 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.54417414 |
| 132 | MP0003724_increased_susceptibility_to | 0.53013449 |
| 133 | MP0000569_abnormal_digit_pigmentation | 0.52565497 |
| 134 | MP0003329_amyloid_beta_deposits | 0.51031944 |
| 135 | MP0000249_abnormal_blood_vessel | 0.50231172 |
| 136 | MP0000343_altered_response_to | 0.49899312 |
| 137 | MP0002938_white_spotting | 0.49809898 |
| 138 | MP0002060_abnormal_skin_morphology | 0.47300523 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.47207826 |
| 140 | MP0005166_decreased_susceptibility_to | 0.46986265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pulmonary artery stenosis (HP:0004415) | 7.07195485 |
| 2 | Redundant skin (HP:0001582) | 6.78181158 |
| 3 | Follicular hyperkeratosis (HP:0007502) | 6.38238685 |
| 4 | Renovascular hypertension (HP:0100817) | 5.99504436 |
| 5 | Hyperacusis (HP:0010780) | 5.87888363 |
| 6 | Elfin facies (HP:0004428) | 5.84033175 |
| 7 | Overriding aorta (HP:0002623) | 5.72838429 |
| 8 | Renal duplication (HP:0000075) | 5.72772462 |
| 9 | Bladder diverticulum (HP:0000015) | 5.57724027 |
| 10 | Broad metatarsal (HP:0001783) | 5.10049782 |
| 11 | Absent frontal sinuses (HP:0002688) | 4.97706095 |
| 12 | Flat cornea (HP:0007720) | 4.91023467 |
| 13 | Insomnia (HP:0100785) | 4.87040838 |
| 14 | Soft skin (HP:0000977) | 4.74350113 |
| 15 | Papilledema (HP:0001085) | 4.66463747 |
| 16 | Cervical subluxation (HP:0003308) | 4.55564669 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 4.44521051 |
| 18 | Premature rupture of membranes (HP:0001788) | 4.37513460 |
| 19 | Aortic regurgitation (HP:0001659) | 4.17222385 |
| 20 | Slender build (HP:0001533) | 4.12765781 |
| 21 | Turricephaly (HP:0000262) | 4.09867465 |
| 22 | Mitral regurgitation (HP:0001653) | 4.04872422 |
| 23 | Spondylolisthesis (HP:0003302) | 4.01674128 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.95147486 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 3.95147486 |
| 26 | Bowel diverticulosis (HP:0005222) | 3.94867354 |
| 27 | Abnormality of the diencephalon (HP:0010662) | 3.81565319 |
| 28 | Arterial tortuosity (HP:0005116) | 3.70566562 |
| 29 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.68243287 |
| 30 | Aortic valve stenosis (HP:0001650) | 3.63823949 |
| 31 | Abnormality of proline metabolism (HP:0010907) | 3.59794578 |
| 32 | Hydroxyprolinuria (HP:0003080) | 3.59794578 |
| 33 | Hypoventilation (HP:0002791) | 3.58497971 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.47624543 |
| 35 | Emphysema (HP:0002097) | 3.43853787 |
| 36 | Increased corneal curvature (HP:0100692) | 3.35016797 |
| 37 | Keratoconus (HP:0000563) | 3.35016797 |
| 38 | Wormian bones (HP:0002645) | 3.32086568 |
| 39 | Adrenal hypoplasia (HP:0000835) | 3.12536559 |
| 40 | Genu recurvatum (HP:0002816) | 3.07391687 |
| 41 | Bronchomalacia (HP:0002780) | 3.06429949 |
| 42 | Wrist flexion contracture (HP:0001239) | 3.06078611 |
| 43 | Persistence of primary teeth (HP:0006335) | 3.00384312 |
| 44 | Hypoplastic toenails (HP:0001800) | 2.99537901 |
| 45 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.93854276 |
| 46 | Shallow orbits (HP:0000586) | 2.92498276 |
| 47 | Abnormality of the frontal sinuses (HP:0002687) | 2.91269931 |
| 48 | Breech presentation (HP:0001623) | 2.87201352 |
| 49 | Ridged nail (HP:0001807) | 2.81290277 |
| 50 | Fragile skin (HP:0001030) | 2.81258488 |
| 51 | Elbow flexion contracture (HP:0002987) | 2.80204830 |
| 52 | Short nail (HP:0001799) | 2.79979957 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.77048462 |
| 54 | Hypercalcemia (HP:0003072) | 2.74545581 |
| 55 | Arnold-Chiari malformation (HP:0002308) | 2.66795518 |
| 56 | Abnormal delivery (HP:0001787) | 2.64152323 |
| 57 | Joint laxity (HP:0001388) | 2.61409512 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.58386117 |
| 59 | Abnormal cartilage morphology (HP:0002763) | 2.56781683 |
| 60 | Bell-shaped thorax (HP:0001591) | 2.51091658 |
| 61 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.50698326 |
| 62 | Megalocornea (HP:0000485) | 2.46869556 |
| 63 | Deviation of the hallux (HP:0010051) | 2.46790875 |
| 64 | Neonatal short-limb short stature (HP:0008921) | 2.45723232 |
| 65 | Increased nuchal translucency (HP:0010880) | 2.44515801 |
| 66 | Wide anterior fontanel (HP:0000260) | 2.44469755 |
| 67 | Blue sclerae (HP:0000592) | 2.42883351 |
| 68 | Ovoid vertebral bodies (HP:0003300) | 2.41821974 |
| 69 | Long toe (HP:0010511) | 2.40722246 |
| 70 | Coronal craniosynostosis (HP:0004440) | 2.38595433 |
| 71 | Protruding ear (HP:0000411) | 2.38027249 |
| 72 | Hyperextensible skin (HP:0000974) | 2.36972738 |
| 73 | Short hallux (HP:0010109) | 2.32230101 |
| 74 | Knee flexion contracture (HP:0006380) | 2.32022772 |
| 75 | Hypercalciuria (HP:0002150) | 2.29404669 |
| 76 | Flared iliac wings (HP:0002869) | 2.27291859 |
| 77 | Delayed gross motor development (HP:0002194) | 2.26257130 |
| 78 | Vascular tortuosity (HP:0004948) | 2.24438040 |
| 79 | Biconcave vertebral bodies (HP:0004586) | 2.23576340 |
| 80 | Atrophic scars (HP:0001075) | 2.21968658 |
| 81 | Concave nail (HP:0001598) | 2.18773894 |
| 82 | Inguinal hernia (HP:0000023) | 2.18571169 |
| 83 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.18094916 |
| 84 | Femoral bowing (HP:0002980) | 2.15121006 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.14885437 |
| 86 | Abnormality of the gastric mucosa (HP:0004295) | 2.14846550 |
| 87 | Abnormality of the acetabulum (HP:0003170) | 2.14508111 |
| 88 | Joint stiffness (HP:0001387) | 2.14036347 |
| 89 | Overgrowth (HP:0001548) | 2.13770951 |
| 90 | Pulmonic stenosis (HP:0001642) | 2.13116476 |
| 91 | Flat capital femoral epiphysis (HP:0003370) | 2.11289190 |
| 92 | Hypoplasia of the odontoid process (HP:0003311) | 2.07062106 |
| 93 | Mitral stenosis (HP:0001718) | 2.06098981 |
| 94 | Broad ribs (HP:0000885) | 2.05939252 |
| 95 | Mitral valve prolapse (HP:0001634) | 2.05783421 |
| 96 | Aortic dissection (HP:0002647) | 2.04419255 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03844671 |
| 98 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.03519970 |
| 99 | Limb-girdle muscle weakness (HP:0003325) | 2.02094779 |
| 100 | Posterior embryotoxon (HP:0000627) | 2.00774832 |
| 101 | Hallux valgus (HP:0001822) | 2.00057367 |
| 102 | Delayed cranial suture closure (HP:0000270) | 1.99333823 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.98072315 |
| 104 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96862397 |
| 105 | Glossoptosis (HP:0000162) | 1.96704926 |
| 106 | Trismus (HP:0000211) | 1.96301757 |
| 107 | Hypochromic microcytic anemia (HP:0004840) | 1.95866246 |
| 108 | Aortic aneurysm (HP:0004942) | 1.95296393 |
| 109 | Infantile muscular hypotonia (HP:0008947) | 1.94958050 |
| 110 | Hydroureter (HP:0000072) | 1.94776925 |
| 111 | Nonimmune hydrops fetalis (HP:0001790) | 1.93400444 |
| 112 | Ankyloglossia (HP:0010296) | 1.92294186 |
| 113 | Mesomelia (HP:0003027) | 1.91648865 |
| 114 | Abnormality of the odontoid process (HP:0003310) | 1.91538141 |
| 115 | Epiphyseal dysplasia (HP:0002656) | 1.90926270 |
| 116 | Camptodactyly of toe (HP:0001836) | 1.88359872 |
| 117 | Hip contracture (HP:0003273) | 1.87976100 |
| 118 | Multiple enchondromatosis (HP:0005701) | 1.87758167 |
| 119 | Round ear (HP:0100830) | 1.87110528 |
| 120 | Abnormality of the line of Schwalbe (HP:0008048) | 1.86772771 |
| 121 | Periorbital edema (HP:0100539) | 1.85821866 |
| 122 | Patellar dislocation (HP:0002999) | 1.85174341 |
| 123 | Aplasia of the musculature (HP:0100854) | 1.82136441 |
| 124 | Generalized amyotrophy (HP:0003700) | 1.81706537 |
| 125 | Congenital glaucoma (HP:0001087) | 1.81071767 |
| 126 | Narrow nasal bridge (HP:0000446) | 1.80519041 |
| 127 | Upper limb muscle weakness (HP:0003484) | 1.79896044 |
| 128 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.79805215 |
| 129 | Single umbilical artery (HP:0001195) | 1.79805215 |
| 130 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.79805215 |
| 131 | Morphological abnormality of the middle ear (HP:0008609) | 1.79497425 |
| 132 | Cerebral aneurysm (HP:0004944) | 1.78588882 |
| 133 | Osteoarthritis (HP:0002758) | 1.77178754 |
| 134 | Increased connective tissue (HP:0009025) | 1.76027895 |
| 135 | Bulbous nose (HP:0000414) | 1.75854333 |
| 136 | Facial edema (HP:0000282) | 1.75011375 |
| 137 | Tarsal synostosis (HP:0008368) | 1.74917954 |
| 138 | Limited hip movement (HP:0008800) | 1.74797107 |
| 139 | Dilatation of the ascending aorta (HP:0005111) | 1.74793141 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.72440124 |
| 141 | Bradycardia (HP:0001662) | 1.71809232 |
| 142 | Vertebral arch anomaly (HP:0008438) | 1.71239571 |
| 143 | Buphthalmos (HP:0000557) | 1.70929864 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.70357817 |
| 145 | Upper limb amyotrophy (HP:0009129) | 1.70357817 |
| 146 | Mesangial abnormality (HP:0001966) | 1.70137596 |
| 147 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.67884512 |
| 148 | Thoracolumbar scoliosis (HP:0002944) | 1.67614437 |
| 149 | Ankle contracture (HP:0006466) | 1.67458944 |
| 150 | Abnormality of the pulmonary veins (HP:0011718) | 1.67369341 |
| 151 | Premature skin wrinkling (HP:0100678) | 1.65947146 |
| 152 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65826750 |
| 153 | Abnormality of the lumbar spine (HP:0100712) | 1.65636733 |
| 154 | Disproportionate short-trunk short stature (HP:0003521) | 1.65466766 |
| 155 | Humeroradial synostosis (HP:0003041) | 1.65082865 |
| 156 | Synostosis involving the elbow (HP:0003938) | 1.65082865 |
| 157 | Abnormality of dentin (HP:0010299) | 1.64911200 |
| 158 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.64537626 |
| 159 | Peritonitis (HP:0002586) | 1.64529357 |
| 160 | Aneurysm (HP:0002617) | 1.63494275 |
| 161 | Enlarged penis (HP:0000040) | 1.63338545 |
| 162 | Widely patent fontanelles and sutures (HP:0004492) | 1.60785560 |
| 163 | Spinal rigidity (HP:0003306) | 1.59222080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMX | 5.74368230 |
| 2 | ACVR1B | 4.98249225 |
| 3 | MYLK | 4.91379566 |
| 4 | NME1 | 4.88142132 |
| 5 | MAP3K2 | 4.86584338 |
| 6 | MAP3K4 | 3.80864080 |
| 7 | MAP3K14 | 3.25472061 |
| 8 | CDK12 | 3.10430065 |
| 9 | TGFBR2 | 2.87467654 |
| 10 | PRKD2 | 2.35718339 |
| 11 | MAP3K7 | 2.29788331 |
| 12 | STK38 | 2.26327121 |
| 13 | EPHB2 | 2.13953541 |
| 14 | FRK | 2.12790802 |
| 15 | INSRR | 2.09665952 |
| 16 | AKT3 | 2.01947397 |
| 17 | MAP3K13 | 1.97755031 |
| 18 | PINK1 | 1.94714119 |
| 19 | BMPR1B | 1.87246068 |
| 20 | PAK2 | 1.80095385 |
| 21 | RIPK4 | 1.79317765 |
| 22 | PIK3CG | 1.77387010 |
| 23 | BCR | 1.73703116 |
| 24 | DDR2 | 1.73527821 |
| 25 | FGR | 1.71324786 |
| 26 | MAP3K12 | 1.62345129 |
| 27 | PAK3 | 1.54090774 |
| 28 | LATS2 | 1.52452443 |
| 29 | NUAK1 | 1.48762751 |
| 30 | DMPK | 1.48088627 |
| 31 | EPHA4 | 1.43518482 |
| 32 | PNCK | 1.37687793 |
| 33 | MAPKAPK3 | 1.36947423 |
| 34 | WNK1 | 1.36822348 |
| 35 | GRK5 | 1.35077646 |
| 36 | FLT3 | 1.33740821 |
| 37 | STK38L | 1.32511148 |
| 38 | PTK2B | 1.32384479 |
| 39 | WNK4 | 1.29328525 |
| 40 | ERN1 | 1.26358793 |
| 41 | PIM2 | 1.26124623 |
| 42 | TRPM7 | 1.23614927 |
| 43 | TESK1 | 1.22873019 |
| 44 | CDK8 | 1.17289792 |
| 45 | NEK9 | 1.11972746 |
| 46 | MOS | 1.09414904 |
| 47 | STK3 | 1.08659680 |
| 48 | KSR2 | 1.04902252 |
| 49 | TGFBR1 | 1.04738607 |
| 50 | CASK | 1.03091025 |
| 51 | JAK3 | 1.01882977 |
| 52 | KIT | 1.00415153 |
| 53 | MET | 1.00018597 |
| 54 | PDGFRB | 0.96508160 |
| 55 | PRKG2 | 0.93752453 |
| 56 | MAPK13 | 0.89547055 |
| 57 | SIK1 | 0.89483632 |
| 58 | PAK6 | 0.87155075 |
| 59 | PRKCH | 0.86608854 |
| 60 | BMPR2 | 0.85046488 |
| 61 | DAPK3 | 0.84949482 |
| 62 | MAP3K3 | 0.84657568 |
| 63 | LIMK1 | 0.83501293 |
| 64 | MARK1 | 0.80162956 |
| 65 | EIF2AK2 | 0.79121117 |
| 66 | NME2 | 0.77797173 |
| 67 | GRK6 | 0.77289894 |
| 68 | GRK7 | 0.76176423 |
| 69 | RIPK1 | 0.71798496 |
| 70 | MAPK7 | 0.71100076 |
| 71 | MAP4K2 | 0.70110131 |
| 72 | STK16 | 0.70029528 |
| 73 | STK10 | 0.68410244 |
| 74 | HIPK2 | 0.66656477 |
| 75 | FGFR1 | 0.66453375 |
| 76 | MAP2K7 | 0.66409027 |
| 77 | NTRK2 | 0.66029588 |
| 78 | JAK1 | 0.64922545 |
| 79 | ROCK2 | 0.64486204 |
| 80 | DYRK1A | 0.64459310 |
| 81 | MKNK2 | 0.62603721 |
| 82 | LRRK2 | 0.62539337 |
| 83 | PAK4 | 0.61690108 |
| 84 | MUSK | 0.61346021 |
| 85 | TTN | 0.60695679 |
| 86 | PRKCD | 0.59541089 |
| 87 | MAPKAPK2 | 0.59264789 |
| 88 | ADRBK2 | 0.58148204 |
| 89 | PRKCQ | 0.57359456 |
| 90 | CAMKK2 | 0.56626478 |
| 91 | ERBB4 | 0.56624682 |
| 92 | CDK7 | 0.55627198 |
| 93 | EGFR | 0.55537131 |
| 94 | PRKCG | 0.53935552 |
| 95 | PRKD3 | 0.53700381 |
| 96 | GSK3A | 0.53573302 |
| 97 | CAMK2G | 0.52782767 |
| 98 | PBK | 0.52687712 |
| 99 | MAP2K2 | 0.52442601 |
| 100 | MKNK1 | 0.52392121 |
| 101 | PDGFRA | 0.51641117 |
| 102 | ADRBK1 | 0.49647493 |
| 103 | CDC42BPA | 0.49065287 |
| 104 | TNIK | 0.48638602 |
| 105 | MAPK11 | 0.47090416 |
| 106 | ABL2 | 0.47023302 |
| 107 | CDK5 | 0.46761626 |
| 108 | LMTK2 | 0.46733586 |
| 109 | NTRK1 | 0.46721384 |
| 110 | PLK2 | 0.46510119 |
| 111 | CAMK1 | 0.45851786 |
| 112 | MAPKAPK5 | 0.45675778 |
| 113 | TAOK3 | 0.45310466 |
| 114 | TBK1 | 0.44333718 |
| 115 | DYRK3 | 0.43165707 |
| 116 | IKBKB | 0.42851235 |
| 117 | RPS6KA2 | 0.41409211 |
| 118 | WNK3 | 0.40961340 |
| 119 | MELK | 0.40837803 |
| 120 | FYN | 0.40014236 |
| 121 | GRK1 | 0.39989427 |
| 122 | PIK3CA | 0.39356789 |
| 123 | PTK2 | 0.38614175 |
| 124 | CDK6 | 0.38480363 |
| 125 | PRKD1 | 0.37807273 |
| 126 | EPHA3 | 0.36673706 |
| 127 | INSR | 0.36552774 |
| 128 | CAMK2D | 0.34038667 |
| 129 | SRC | 0.33187708 |
| 130 | RAF1 | 0.32736040 |
| 131 | LATS1 | 0.32207317 |
| 132 | PRKCE | 0.32122516 |
| 133 | CAMK2A | 0.32065684 |
| 134 | MAPK15 | 0.31606735 |
| 135 | CHUK | 0.31212429 |
| 136 | IRAK3 | 0.30968397 |
| 137 | CSNK1G2 | 0.29908726 |
| 138 | IGF1R | 0.29668288 |
| 139 | CSNK1D | 0.29442368 |
| 140 | TIE1 | 0.29065898 |
| 141 | PDK2 | 0.27980760 |
| 142 | EPHB1 | 0.27469290 |
| 143 | CSNK1E | 0.26200171 |
| 144 | MINK1 | 0.25897208 |
| 145 | CDK14 | 0.25570630 |
| 146 | STK11 | 0.24695636 |
| 147 | ILK | 0.23333792 |
| 148 | CDK15 | 0.23226383 |
| 149 | MAP3K1 | 0.22472627 |
| 150 | DYRK1B | 0.22184587 |
| 151 | MAPK3 | 0.22141589 |
| 152 | MAPK4 | 0.22120689 |
| 153 | MAP2K1 | 0.21268780 |
| 154 | MAPK14 | 0.20919167 |
| 155 | MATK | 0.20814751 |
| 156 | ROCK1 | 0.20012076 |
| 157 | PRKCA | 0.19867707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.79664752 |
| 2 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.46987304 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.40242964 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.28107445 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.01531631 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.74171272 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.57108759 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.17631727 |
| 9 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.14103479 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.13142429 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.04745060 |
| 12 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.99564775 |
| 13 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.90500658 |
| 14 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.87046787 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74993712 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71050499 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69810379 |
| 18 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.59760253 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59024150 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.56559364 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.55381425 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54299789 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.48531089 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.48234691 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41524374 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39770592 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.38481800 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34243643 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34019176 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31967091 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31466398 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.30840877 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30627397 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26512121 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26128536 |
| 36 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.24416767 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.19439848 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.18749261 |
| 39 | Melanoma_Homo sapiens_hsa05218 | 1.18666783 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.18500363 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18187996 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17541267 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16840845 |
| 44 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.16681396 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16224781 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.15995089 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15261865 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.14718162 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.13586255 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12749557 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11320460 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09686499 |
| 53 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.04331879 |
| 54 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01022230 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00515999 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00329384 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98759126 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.98312734 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.96818375 |
| 60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94733801 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.94144028 |
| 62 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92575764 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92100338 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91612076 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91333255 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91152431 |
| 67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.89906364 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88950405 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.87579403 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86484844 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.84711532 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.84504497 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83466304 |
| 74 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.82524928 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82505350 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81917237 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81233299 |
| 78 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.81076119 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80606202 |
| 80 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79732527 |
| 81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79225126 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.77941254 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75826951 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74647264 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73217400 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.72999665 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72834235 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72537916 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69879004 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69864269 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69034233 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66214176 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65962855 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64575272 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63736324 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63265805 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.63162943 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62874536 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62774819 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.61955838 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61499527 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60600863 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60145892 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59117111 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59079027 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59061440 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.59042131 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.58081428 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55941345 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54170536 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53638588 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53518290 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53223630 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52227022 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.52195818 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50568041 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48930805 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47695199 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46248699 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.46233463 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45372208 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.44872409 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.44592438 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43384751 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.43065282 |
| 126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41981919 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41422065 |
| 128 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40540715 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.40502009 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40196006 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39785768 |
| 132 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39694281 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39578954 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36977399 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.36872861 |
| 136 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36857777 |
| 137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36790500 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36595847 |
| 139 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36519769 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36107382 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35585273 |
| 142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35537385 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.34433649 |
| 144 | Salivary secretion_Homo sapiens_hsa04970 | 0.33919072 |
| 145 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33711586 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31081492 |
| 147 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30808940 |

